肥厚型心肌病心源性猝死风险计算器在亚洲人群中的验证
该研究在730例韩国肥厚型心肌病患者中验证2014年欧洲心脏病学会推荐的HCM Risk-SCD计算器,随访4288人年,16例(2.2%)达到主要终点。计算器校准斜率为0.892,C统计量为0.718,阴性预测值高但部分终点事件被误分至低危或中危组,加入性别变量可显著改善预测价值。
要点
- HCM Risk-SCD计算器在韩国人群中C统计量0.718,校准斜率0.892。
- 低危组终点事件1.1%(7/615),中危组4.6%(3/65),高危组12.0%(6/50)。
- 63.6%(7/11)的SCD发生在低危组,提示计算器可能低估部分患者风险。
核心结论
- 在韩国HCM人群中,HCM Risk-SCD计算器对SCD或适当ICD治疗具有高阴性预测值和准确性,但将少数发生主要终点的患者误分为低危或中危组。
研究设计与样本
- 观察性纵向队列研究,纳入2007至2017年730例韩国HCM患者,随访4288人年,主要终点为SCD与适当ICD治疗的复合终点。
主要发现
- 随访期间16例(2.2%)患者达到主要终点,计算器校准斜率为0.892,C统计量为0.718。
- 主要终点在低危、中危、高危组的发生率分别为1.1%(7/615)、4.6%(3/65)、12.0%(6/50)。
- 85.2%未发生主要终点的患者被归为低危组,但11例SCD中7例(63.6%)发生在低危组。
- 单变量和多变量分析中,女性与主要终点显著相关并成为独立预测因子。
- 将性别加入HCM Risk-SCD计算器显著改善主要终点的预测价值(净重分类改善0.557,p=0.015)。
临床怎么用
- 在亚洲HCM患者中可使用HCM Risk-SCD计算器进行风险分层,但其阴性预测值较高而阳性预测值有限。
- 对计算器判为低危的患者仍需结合性别等额外因素综合评估SCD风险。
局限性
- 研究为单国人群观察性队列,样本量有限,主要终点事件数较少。
- 原文未报告计算器在亚洲其他人群中的外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The hypertrophic cardiomyopathy (HCM) risk-sudden cardiac death (SCD) calculator endorsed by the 2014 European Society of Cardiology has not been independently validated in the Asians. We aimed to investigate whether the HCM Risk-SCD calculator effectively predicts SCD in Korean HCM population. METHODS: An observational, longitudinal cohort study was performed in 730 patients with HCM from 2007 to 2017. The primary endpoint was a composite of SCD and appropriate implantable cardioverter-defibrillator (ICD) therapy. RESULTS: During a follow-up period of 4288 person-years, 16 (2.2%) patients reached the primary endpoint. This validation study revealed a calibration slope of 0.892 and C-statistics of 0.718. The primary endpoint occurred in 1.1% (7/615), 4.6% (3/65) and 12.0% (6/50) of low-risk, intermediate-risk and high-risk groups, respectively. Although most patients (85.2%) without the primary endpoint were classified into the low-risk group, 7 of 11 SCD (63.6%) occurred in the low-risk group. In univariable and multivariable analysis, sex (woman) was significantly associated with the primary endpoint and emerged as independent predictor. The addition of sex to the HCM Risk-SCD calculator significantly improved the predictive value of the primary endpoint (net reclassification improvement 0.557, p=0.015). CONCLUSIONS: In the Korean HCM population, the HCM Risk-SCD calculator had a high negative predictive value and accuracy for predicting SCD or appropriate ICD therapy, but misclassified a few patients experiencing the primary endpoint as low-risk or intermediate-risk groups.
引用
- Choi YJ, Kim HK, Lee SC, et al. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians. Heart. 2019. PMID: 31383719. doi:10.1136/heartjnl-2019-315160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。